FDA Brief

Warning letters Drugs

FDA warning letter to

onlineotcmeds.com

High riskIssued Oct 15, 2025Posted Nov 4, 2025Center for Drug Evaluation and Research (CDER)

FDA warned onlineotcmeds.com for selling unapproved, misbranded opioids, benzodiazepines, and Schedule II stimulants to U.S. consumers online.

What happened

FDA reviewed the website onlineotcmeds.com and found it offering prescription opioids, benzodiazepines, and Schedule II stimulants for sale to U.S. consumers without a prescription. FDA says the site marketed these as drugs for human use but had no FDA-approved applications for them. FDA also says the labeling lacked adequate directions for use, making them misbranded.

What FDA found

  1. FDA says the website offered opioids, benzodiazepines, and Schedule II stimulants that are unapproved new drugs because no FDA-approved applications are in effect for them.

    FD&C Act sections 301(d) and 505(a) [21 U.S.C. §§ 331(d), 355(a)]
  2. FDA says the drugs are misbranded because their labeling does not give adequate directions for use by a layperson.

    FD&C Act section 502(f)(1) [21 U.S.C. § 352(f)(1)]
  3. FDA says the website offered prescription drugs for sale without a prescription.

    FD&C Act sections 503(b)(1) and 301(k) [21 U.S.C. §§ 353(b)(1), 331(k)]

What FDA wants

FDA asks onlineotcmeds.com to stop offering any unapproved and misbranded drugs to U.S. consumers. It asks the company to reply in writing within 15 working days with the steps taken to correct the violations and prevent recurrence.

Who should pay attention

  • online pharmacies selling prescription drugs
  • platforms that host or link to pharmacy websites
  • brands whose prescription drug names are used by rogue sellers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk